Cutler Group LP Trans Medics Group, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$70.86 - $89.93 $7,086 - $8,993	100 New	100 $0
Q2 2023 Jul 18, 2023	SELL	$66.23 - $88.73 $19,869 - $26,619	-300 Reduced 75.0%	100 $1,000
Q1 2023 May 01, 2023	BUY	$53.63 - $82.33 $21,452 - $32,932	400 New	400 $12,000
Q4 2021 Jan 18, 2022	SELL	$19.16 - $32.68 $15,328 - $26,144	-800 Reduced 44.44%	1,000 $0
Q2 2021 Jul 19, 2021	SELL	$21.63 - $40.07 $296,331 - $548,959	-13,700 Reduced 88.39%	1,800 $7,000
Q1 2021 Apr 26, 2021	BUY	$17.75 - $47.82 $275,125 - $741,210	15,500 New	15,500 $55,000

358

29.6M

399K

154K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $5B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.